What is NDC 25021-111?

25021-111 is the product NDC for Cefoxitin, Cefoxitin sodium 10 g/1 injection, powder, for solution, listed with the FDA by Sagent Pharmaceuticals. It has 1 package NDC, shown above in 10- and 11-digit form.

Sagent Pharmaceuticals, NDC labeler code 25021. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Cefoxitin?

11 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Cefoxitin NDC 25021-111 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)25021-111Labeler and product segments. Claims need a package NDC.

Product NDC at billing width25021-0111Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
25021-111-99	2502101119925021011199	10 BOTTLE in 1 CARTON (25021-111-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 BOTTLEMarketed from Aug 12, 2010

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Cefoxitin
Generic name (nonproprietary): cefoxitin
Active ingredients: Cefoxitin sodium — 10 g/1
Dosage form: Injection, Powder, For solution
Route: Intravenous
Labeler: Sagent PharmaceuticalsNDC labeler code 25021
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 065415
Marketing start: Aug 12, 2010
Listing expires: Dec 31, 2026
Other FDA classes: Cephalosporins (Chemical structure)
Identifiers: Product ID 25021-111_79813968-4f6f-49a9-9a94-18607a1bcfbfSPL ID 79813968-4f6f-49a9-9a94-18607a1bcfbfSPL set ID 4c6f7665-204f-6c69-7669-61204d756e6eRxCUI 309072UNII Q68050H03T
Pharmacologic class: Cephalosporin Antibacterial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N425021011199 followed by a unit qualifier and the quantity

Package 25021-0111-99. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 9, 2020. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Treatment Cefoxitin for Injection, USP is indicated for the treatment of serious infections caused by susceptible strains of the designated microorganisms in the diseases listed below. (1) Lower respiratory tract infections , including pneumonia and lung abscess, caused by Streptococcus pneumoniae , other streptococci (excluding enterococci, e.g., Enterococcus faecalis [formerly Streptococcus faecalis ]), Staphylococcus aureus (including penicillinase-producing strains), Escherichia coli , Klebsiella species, Haemophilus influenzae, and Bacteroides species. (2) Urinary tract infections caused by Escherichia coli , Klebsiella species, Proteus mirabilis , Morganella morga…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 25021-111

What is NDC 25021-111?: 25021-111 is the product NDC for Cefoxitin, Cefoxitin sodium 10 g/1 injection, powder, for solution, listed with the FDA by Sagent Pharmaceuticals. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Cefoxitin.
What is the active ingredient?: Cefoxitin sodium.
Who is the labeler?: Sagent Pharmaceuticals, NDC labeler code 25021. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Cefoxitin?: 11 other product NDCs are listed under this name. See all Cefoxitin NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Cefoxitin NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Cefoxitin	Cefoxitin sodium 2 g/1	Injection, Powder, For solutionIntravenous	WG Critical Care, LLC	44567-246	44567-0246-85
Cefoxitin	Cefoxitin sodium 100 g/1	Injection, Powder, For solutionIntravenous	SAMSON MEDICAL TECHNOLOGIES LLC	66288-4100	66288-4100-01
Cefoxitin	Cefoxitin sodium 1 g/1	Injection, Powder, For solutionIntravenous	WG Critical Care, LLC	44567-245	44567-0245-25
Cefoxitin	Cefoxitin sodium 10 g/1	Injection, Powder, For solutionIntravenous	WG Critical Care, LLC	44567-247	44567-0247-10
Cefoxitincefoxitin sodium	Cefoxitin sodium 1 g/1	Powder, For solutionIntravenous	Fresenius Kabi USA, LLC	63323-341	63323-0341-29
Cefoxitincefoxitin sodium	Cefoxitin sodium 2 g/1	Powder, For solutionIntravenous	Fresenius Kabi USA, LLC	63323-342	63323-0342-29
Cefoxitin	Cefoxitin sodium 2 g/1	Injection, Powder, For solutionIntravenous	Hikma Pharmaceuticals USA Inc.	0143-9877	00143-9877-25
Cefoxitin	Cefoxitin sodium 1 g/1	Injection, Powder, For solutionIntravenous	Hikma Pharmaceuticals USA Inc.	0143-9878	00143-9878-25
Cefoxitin	Cefoxitin sodium 10 g/1	Injection, Powder, For solutionIntravenous	Hikma Pharmaceuticals USA Inc.	0143-9876	00143-9876-10
Cefoxitin	Cefoxitin sodium 1 g/1	Injection, Powder, For solutionIntravenous	Sagent Pharmaceuticals	25021-109	25021-0109-10

All 12 Cefoxitin NDCs

Other NDCs under ANDA 065415

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 065415
Product	Strength	Form · route	Labeler	Product NDC
Cefoxitin	Cefoxitin sodium 10 g/1	Injection, Powder, For solutionIntravenous	WG Critical Care, LLC	44567-247